Resilience US, Inc. Capacity Update February 2024: Large Molecule
Source: Resilience US, Inc.
Founded in 2020, Resilience is a technology-focused biomanufacturing company dedicated to broadening access to complex medicines. With a strong network of sites across six states and one in Canada, Resilience provides innovative solutions and services for established and emerging therapies. Hear Evan Pasenello, Business Head of Biologics & Vaccines, discuss how Resilience can support your development and manufacturing programs.
access the Video!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Outsourced Pharma? Subscribe today.
Subscribe to Outsourced Pharma
X
Subscribe to Outsourced Pharma
Resilience US, Inc.
This website uses cookies to ensure you get the best experience on our website. Learn more